Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 5
Results: 15
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 743, doi. 10.1007/s00262-019-02316-w
- By:
- Publication type:
- Article
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 787, doi. 10.1007/s00262-019-02313-z
- By:
- Publication type:
- Article
Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 753, doi. 10.1007/s00262-018-02297-2
- By:
- Publication type:
- Article
Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 709, doi. 10.1007/s00262-018-02292-7
- By:
- Publication type:
- Article
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 861, doi. 10.1007/s00262-019-02336-6
- By:
- Publication type:
- Article
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 705, doi. 10.1007/s00262-019-02335-7
- By:
- Publication type:
- Article
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 849, doi. 10.1007/s00262-018-2276-z
- By:
- Publication type:
- Article
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 799, doi. 10.1007/s00262-019-02315-x
- By:
- Publication type:
- Article
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 835, doi. 10.1007/s00262-018-2269-y
- By:
- Publication type:
- Article
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 731, doi. 10.1007/s00262-019-02314-y
- By:
- Publication type:
- Article
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 765, doi. 10.1007/s00262-019-02311-1
- By:
- Publication type:
- Article
Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 721, doi. 10.1007/s00262-019-02312-0
- By:
- Publication type:
- Article
Opposing roles of eosinophils in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 823, doi. 10.1007/s00262-018-2255-4
- By:
- Publication type:
- Article
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 773, doi. 10.1007/s00262-019-02307-x
- By:
- Publication type:
- Article
Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 813, doi. 10.1007/s00262-018-2229-6
- By:
- Publication type:
- Article